In 2022, our group has contributed to relevant studies on our 3 main research lines (traumatic brain injury, hydrocephalus, and congenital malformations of the craniovertebral junction -CVJ-). As the most relevant contributions, we highlight the studies we have carried out on the non-invasive measurement of intracranial pressure through transcutaneous optical monitoring systems and the study of the repercussions of hyperventilation or cerebral anaemia on cerebral hemodynamics in neurocritical patients through this same non-invasive monitoring system. In the line of congenital malformations of the CVJ, our greatest contribution has been our participation in the consensus conference on developing clinical practice guidelines for diagnosing and treating these malformations in adults and children, which have given rise to two specific publications. Finally, our Unit has obtained important competitive funding, national and European, in the three active lines of research.
Group Leader
Ma Antonia Poca Pastor
Principal Investigator (PI)
Juan Sahuquillo Barris, Miriam De Nadal Clanchet, Fuat Arikan Abelló
Researchers
Francisca Munar Bauzá, Alejandro Ferré Masó, Dulce Moncho Rodríguez, María Sueiras Gil, Darío Fabián Gándara Sabatini, Francisco Ramon Martínez-Ricarte, Marcelino Báguena Martínez, Marilyn Riveiro Vilaboa, Anna Rey Pérez, Jacinto Baena Caparrós
PhD Students
Federica Maruccia, David Sánchez Ortiz, Marta Peris Sales
Lab Technicians
Noelia Montoya Clemente
Nursing and Technical Staff
Lourdes Expósito Mozas, Monica Tarradas Ustrell
37
PUBLICATIONS
35.1%
%Q1
547
IMPACT FACTOR
14.79
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
Maruccia F, Tagliabue S, Fischer JB, Kacprzak M, Pérez-Hoyos S, Rosas K, Álvarez ID, Sahuquillo J, Durduran T, Poca MA
Transcranial optical monitoring for detecting intracranial pressure alterations in children with benign external hydrocephalus: a proof-of-concept study
Neurophotonics 2022 Oct;9(4):045005. doi: 10.1117/1.NPh.9.4.045005. Epub 2022 Nov 17
DOI: doi: 10.1117/1.NPh.9.4.045005
IF: 4.212
Massimi L, Peretta P, Erbetta A, Solari A, Farinotti M, Ciaramitaro P, Saletti V, Caldarelli M, Canheu AC, Celada C, Chiapparini L, Chieffo D, Cinalli G, Di Rocco F, Furlanetto M, Giordano F, Jallo G, James S, Lanteri P, Lemarchand C, Messing-Jünger M, Parazzini C, Paternoster G, Piatelli G, Poca MA, Prabahkar P, Ricci F, Righini A, Sala F, Sahuquillo J, Stoodley M, Talamonti G, Thompson D, Triulzi F, Zucchelli M, Valentini L; International Experts - Jury of the Chiari & Syringomyelia Consensus Conference, “Milan, November 11–13, 2019”
Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document
Neurological sciences 2022 Feb;43(2):1311-1326. Epub 2021 Jun 7
DOI: doi: 10.1007/s10072-021-05317-9
IF: 3.307
Ciaramitaro P, Massimi L, Bertuccio A, Solari A, Farinotti M, Peretta P, Saletti V, Chiapparini L, Barbanera A, Garbossa D, Valentini L; International Experts Jury of the Chiari Syringomyelia Consensus Conference, Milan, November 11-13, 2019
Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document
Neurological sciences 2022 Feb;43(2):1327-1342. Epub 2021 Jun 15
DOI: doi: 10.1007/s10072-021-05347-3
IF: 3.307
Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K, POISE-3 Investigators
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
The New England journal of medicine 2022 May 26;386(21):1986-1997. Epub 2022 Apr 2
DOI: doi: 10.1056/NEJMoa2201171
IF: 91.253
van Essen TA, Lingsma HF, Pisică D, Singh RD, Volovici V, den Boogert HF, Younsi A, Peppel LD, Heijenbrok-Kal MH, Ribbers GM, Walchenbach R, Menon DK, Hutchinson P, Depreitere B, Steyerberg EW, Maas AIR, de Ruiter GCW, Peul WC; CENTRE-TBI Collaboration Group
Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study
The Lancet. Neurology 2022 Jul;21(7):620-631. Epub 2022 May 5
DOI: 10.1016/S1474-4422(22)00166-1
IF: 44.182
Biomarkers to improve diagnosis and management of mild traumatic brain injury (BRAINI2)
Principal Investigator: Maria Antonia Poca
Agency: EIT Health
Funding: 248,666 €
Period: 2022-2024
Plataforma fotónica no invasiva para la detección a pie de cama de la hipertensión intracraneal y otras anomalías de la dinámica del líquido cerebroespinal (SafeICP)
Principal Investigator: Maria Antonia Poca
Agency: Ministerio de Ciencia
Funding: 239,799.56 €
Period: 2022-2024
Repercusión de la “dilatación” beniga de los espacios subaracnoideos en el desarrollo psicomotor y cognitivo de los niños
Principal Investigator: Maria Antonia Poca
Agency: Instituto de Salud Carlos III
Funding: 81,070 €
Period: 2019-2022
A Global, Multicenter, Open-label, Matched Historical Control Study of Intrathecal SHP611 in Subjects with Late Infantile Metachromatic Leukodystrophy (Phase 2/3).
Principal Investigator: Mireia del Toro
Agency: Shire Human Genetic Therapies Inc
Funding: -
Period: 2019-2022
Estudio prospectivo, aleatorizado, comparativo y multicéntrico, en el que se compara el parche para la reparación de la duramadre artifascia® con sustitutos de la duramadre comercializados
Principal Investigator: Maria Antonia Poca
Agency: Nurami, medical nanofibre technology
Funding: -
Period: 2021-2022
eCOREs
